Patients with CKD are at increased risk of drug accumulation and toxicity due to reduced kidney function. While Iverheal 6 Mg is primarily metabolized in the liver and excreted in feces, its safety profile in CKD patients requires careful consideration. Although there is limited data specifically on Iverheal 6 Mg in CKD, caution is advised, particularly in advanced stages where drug clearance may be significantly impaired.
https://www.flatmeds.com/product/iverheal-6-mg/